Conference call with Founder and CEO Struthers, Chief Endocrinologist Krasner and VP-Clinical Endocrinology Trainer discuss the unmet need in CAH, Cushing’s syndrome, biologic pathways in these diseases and the path going forward following P2 results will be held on May 13 at 11 am hosted by Cantor Fitzgerald. Webcast Link
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRNX:
- Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Crinetics price target raised to $70 from $68 at Citi
- Crinetics reports Q1 EPS (93c), consensus (81c)
- Crinetics Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
- Crinetics Pharmaceuticals Showcases Research at ENDO 2024